- Corporate
Prof. Achim Kaufhold, Chief Medical Officer
 |
Achim Kaufhold, Chief Medical Officer, a German citizen, holds a medical degree from the University of Cologne. During his 10-year academic career he worked in the fields of paediatrics, basic and applied medical microbiology, laboratory medicine and infectious diseases in Germany and the USA. Achim Kaufhold is Professor of Medical Microbiology and Infectious Diseases and a member of the Faculty of Medicine of the University of Aachen, Germany. Dr. Kaufhold has spent more than 16 years in senior management positions in the biotech and pharmaceutical industry, mainly in leadership roles in research, product and business development, and general management. During his industry career he was instrumental in the development, launch and life-cycle management of numerous products in many parts of the world, including Europe and the USA. Prior to joining Basilea, Dr. Kaufhold was President & Chief Executive Officer of Affitech A/S, previously Pharmexa A/S, Denmark. His previous senior management roles included CMO & Vice President of Development, Member of the Executive Committee at Chiron, now part of the Novartis group; CMO, Head of Research, Product & Business Development, Member of the Executive Committee at Berna Biotech, now a Crucell company; and Director Clinical Development & Head of the Pediatric Vaccines Development Unit at GlaxoSmithKline Biologicals with global responsibility for the development of the company´s pediatric vaccine portfolio. |
© 2010 Basilea Pharmaceutica Ltd.
